Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.

J Cell Mol Med 2009 Sep 27;13(9A):2843-52. Epub 2008 Jun 27.

Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.

Chondrosarcomas are highly resistant to conventional radiation and chemotherapy, and surgical removal is the only option for curative treatment. Consequently, there is nothing to offer patients with inoperable tumours and metastatic disease. The aim of this study is to investigate genes involved in cell cycle control: CDK4, CDKN2A/p16, cyclin D1, p21, p53, MDM2 and c-MYC, which may point towards new therapeutic strategies. The pRb pathway was targeted using CDKN2A/p16 overexpressing vectors and shRNA against CDK4 in chondrosarcoma cell lines OUMS27, SW1353, and CH2879. Cell survival and proliferation were assessed. CDK4, MDM2 and c-MYC expression levels were investigated by qPCR and immunohistochemistry (IHC) in 34 fresh frozen and 90 FFPE samples of enchondroma and chondrosarcoma patients. On a subset of 29 high-grade chondrosarcomas IHC for cyclin D1, p21 and p53 was performed. The overexpression of CDKN2A/p16 and knockdown of CDK4 by shRNA in OUMS27, SW1353 and CH2879 resulted in a significant decrease in cell viability and proliferation and a decreased ability to form colonies in vitro. Expression of CDK4 and MDM2 was associated with high-grade chondrosarcoma both at the mRNA and protein level. Combining these results with the expression of cyclin D1 and the previously shown loss of CDKN2A/p16 expression show that the majority (96%; 28/29) of high-grade chondrosarcomas contain alterations in the pRb pathway. This suggests a role for the use of CDK4 inhibitors as a treatment of metastatic or inoperable high-grade chondrosarcoma.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2008.00406.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498940PMC
September 2009
7 Reads

Publication Analysis

Top Keywords

prb pathway
12
cyclin p21
8
sw1353 ch2879
8
oums27 sw1353
8
p21 p53
8
mdm2 c-myc
8
high-grade chondrosarcomas
8
cdk4 mdm2
8
high-grade chondrosarcoma
8
cdk4
7
cell
5
qpcr immunohistochemistry
4
expression levels
4
c-myc expression
4
immunohistochemistry ihc
4
levels investigated
4
investigated qpcr
4
ffpe samples
4
patients subset
4
high-grade
4

References

(Supplied by CrossRef)

Bertoni et al.
2002

Lucas et al.
2002
Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas
Yamaguchi et al.
Anticancer Res. 1996
Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas
Larramendy et al.
Am J Pathol. 1997
p53 Function and dysfunction
Vogelstein et al.
Cell. 1992

Similar Publications